Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025Clinical and Experimental MedicineOpen Access

Integrating multi-omics approaches in acute myeloid leukemia (AML): Advancements and clinical implications

View Full Paper
Ask AI
Bookmark
Share

Authors

HSHamed Soleimani Samarkhazan

Discussion

Loading...

Member takes

Overview

Review demonstrates advancements in multi-omics integration for acute myeloid leukemia, highlighting personalized therapy and biomarker discovery.

Key Points

  • Multi-omics approaches significantly enhance understanding of acute myeloid leukemia (AML) and treatment resistance.
  • Integration of genomics, proteomics, and metabolomics has unveiled novel biomarkers and therapeutic targets in AML.
  • Research leveraging high-throughput techniques has facilitated improved risk stratification and patient therapy selection.
  • Challenges remain in data integration complexity and ethical concerns, impacting the full realization of multi-omics in clinical practice.

Cite This Study

Hamed Soleimani Samarkhazan (2025) studied this question.

synapsesocial.com/papers/68c23966b210217d6477b978https://doi.org/10.1007/s10238-025-01858-x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched one closely related paper. Consider it for comparative context:

  1. 1The microbiome in graft-versus-host disease: a tale of two ecosystems2025 · 28 citations